Medical Condition News

RSS

Transient ischemic attacks are treatable and preventable

An estimated 200,000 Americans experience TIAs each year, and more than one-third will later have full strokes. But TIAs, like strokes, are treatable and preventable.

29 Oct 2009

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

29 Oct 2009

Avon Foundation for Women awards grant to improve reconstructive breast surgery

The Avon Foundation for Women has awarded the Clemson University Institute for Biological Interfaces of Engineering a $195,000 grant to support research to develop new ways to improve reconstructive breast surgery using engineered tissue that contains anti-cancer properties.

29 Oct 2009

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.

29 Oct 2009

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy.

29 Oct 2009

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.

29 Oct 2009

Berkeley HeartLab enters into collaborative agreement

Berkeley HeartLab (BHL), a subsidiary of Celera Corporation, announced today that it has entered into collaborative agreements with Geisinger Medical Center and Proven Diagnostics, a clinical laboratory service recently launched by Geisinger Health System.

29 Oct 2009

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

Although Helicobacter pylori (H. pylori) has been classified as a class I (or definite) carcinogen by World Health Organization (WHO), the controversy as to why only a minority of infected patients develop gastric cancer still remains. Moreover, in Asian countries such as Indonesia, Japan, China, and Thailand, where the H. pylori infection rates are similar, there is a significant difference regarding the outcome of gastric cancer. That fact has been termed the "Asian paradox".

29 Oct 2009

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

Pfizer Canada is pleased to announce the sixth round of recipients of the Pfizer Cardiovascular Research Awards Program. The program, first launched in October 2005, was developed to fund and support cardiovascular research in Canada.

29 Oct 2009

New anti-cancer medications may help in managing cancerous conditions

Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

29 Oct 2009

HD colonoscopy is more sensitive than standard colonoscopy in finding polyps: Study

High-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps that could morph into cancer, say researchers at the Mayo Clinic campus in Florida.

29 Oct 2009

Depressed people more likely to overstate the frequency of physical symptoms

New research shows people who feel depressed tend to recall having more physical symptoms than they actually experienced. The study indicates that depression -- not neuroticism -- is the cause of such over-reporting.

29 Oct 2009

$5.5 million grant to Cedars-Sinai Heart Institute for development of cardiac stem cell therapies

A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.

29 Oct 2009

CAMH Foundation receives $5 million gift for mental health research

An extraordinary gift of $5 million from Mr. G. Raymond Chang, Chancellor of Ryerson University and Chair of CI Financial, will go toward furthering research and education about the treatment of mental health and addictions, the Centre for Addiction and Mental Health (CAMH) Foundation announced today.

29 Oct 2009

Moores UCSD Cancer Center awarded $20 million for cancer research

Researchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells.

28 Oct 2009

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease.

28 Oct 2009

NIH awards DiscoveryBioMed grant to develop therapies for cystic fibrosis

DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The $308,000 grant will be used to advance certain small molecule drug discovery programs designed to correct the genetic mutation most common to cystic fibrosis (CF).

28 Oct 2009

NeoChord commences patient enrollment in its TACT European clinical trial

NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.

28 Oct 2009

Philanthropist gifts $10-million to Sunnybrook Foundation

The people of Ontario will have more access than ever to the latest life-saving, minimally invasive cardiovascular treatments thanks to the visionary leadership of one of Canada's foremost philanthropists, Seymour Schulich.

28 Oct 2009

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

Helix BioMedix, Inc., a developer of bioactive peptides, today announced the completion of a series of three clinical studies investigating the safety and efficacy of a serum, eye cream and moisturizer, each containing the Company’s SmartPeptides™ technology, including the newly developed Heptapeptide-7. These studies demonstrate improvement in skin texture and appearance as well as the decrease in fine lines and wrinkles with Striking™ Skin Care formulations.

28 Oct 2009

Medical Condition News

Transient ischemic attacks are treatable and preventable

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

Avon Foundation for Women awards grant to improve reconstructive breast surgery

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

Biomoda to launch multisite Phase III clinical trials of CyPath assay

Berkeley HeartLab enters into collaborative agreement

Lifestyle and genetic factors are considered to play a major role in "Asian paradox"

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

New anti-cancer medications may help in managing cancerous conditions

HD colonoscopy is more sensitive than standard colonoscopy in finding polyps: Study

Depressed people more likely to overstate the frequency of physical symptoms

$5.5 million grant to Cedars-Sinai Heart Institute for development of cardiac stem cell therapies

CAMH Foundation receives $5 million gift for mental health research

Moores UCSD Cancer Center awarded $20 million for cancer research

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

NIH awards DiscoveryBioMed grant to develop therapies for cystic fibrosis

NeoChord commences patient enrollment in its TACT European clinical trial

Philanthropist gifts $10-million to Sunnybrook Foundation

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News